ME

Michael Eisenhut

NA Novartis Ag: 2 patents #28 of 511Top 6%
DK Deutsches Krebsforschungszentrum: 1 patents #13 of 39Top 35%
RH Ruprecht - Karls - Universität Heidelberg: 1 patents #1 of 20Top 5%
Overall (2024): #74,137 of 561,600Top 15%
3
Patents 2024

Issued Patents 2024

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
12054458 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer Jens Cardinale, Martin Schaefer, Klaus Kopka, Matthias Eder, Ulrike Bauder-Wuest +3 more 2024-08-06
11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Martin SCHÄFER, Ulrike BAUDER-WÜST, Walter Mier +1 more 2024-04-09
11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Matthias Eder, Klaus Kopka, Martin SCHÄFER, Ulrike BAUDER-WÜST, Walter Mier +1 more 2024-03-19